Free signup for more
- Track your favorite companies
- Receive email alerts for new filings
- Personalized dashboard of news and more
- Access all data and search results
Content analysis
?Positive | ||
Negative | ||
Uncertain | ||
Constraining | ||
Legalese | ||
Litigous | ||
Readability |
8th grade Avg
|
New words:
ADMETox, Alex, Alexander, amplify, antimicrobial, APEXTM, AppliskanTM, assay, Athena, Australian, Bell, BioImage, Bioreactor, Canada, Cardinal, CB, CombiTM, confirmation, conventional, crystalline, DarwinTM, diffraction, DiscoveryTM, DXR, ELISA, entity, enzyme, exciting, FlashTM, FleetTM, FluoroskanTM, formation, GCTM, gene, Georgia, German, GlaxoSmithKline, guidance, HybaidTM, ideal, incubation, infection, irrevocable, Kaufman, kinetic, KingFisherTM, KRILPROTM, likelihood, luminometer, LuminoskanTM, microbial, microscopy, modulate, Multidrop, multimode, MultiskanTM, Mumbai, NanoDrop, Nanogen, NautilusTM, NE, neurological, noncontrolling, nonmonetary, OmniTM, Oryx, pocket, proposed, pump, QPCR, QSPTM, QuantoDesk, quarry, rata, receipt, recipient, renal, robust, SampleManagerTM, scalability, sealing, solid, spectrophotometry, statute, synthetic, tank, therapy, TLP, twelve, UHPLC, unattended, Union, Varioskan, VersaWeigh, VTM, washer, WEEE, winning
Removed:
AB, abuse, AC, advisory, aggregated, auger, beam, Counseling, diffractometry, downturn, epitaxy, expenditure, Graseby, grew, headcount, InnaPhase, intention, liquidate, microspectroscopy, mixture, nearest, noncash, noncurrent, nonoperating, nonqualified, NW, photoelectron, publicly, reclassification, refunded, replaced, restoration, Saturday, simplify, sized, spectra, spinning, spun, subsidiary, ThermoLase, ThermoQuest, VG
Filing tables
Filing exhibits
- 10-K Annual report
- PDF TMO 10-K 2007 (PDF Version)
- 3.3 TMO 10-K 2007 Exhibit 3.3 (Bylaws of the Company)
- 10.70 TMO 10-K Exhibit 10.70 (Executive Change In Control Retention Agreement)
- 10.71 TMO 10-K 2007 Exhibit 10.71 (Fsii Severance Plan for Key Employees)
- 10.72 TMO 10-K 2007 Exhibit 10.72 (Notice of Participation - Alex Stachtiaris)
- 10.73 TMO 10-K 2007 Exhibit 10.73 (Notice of Participation - Alan Malus)
- 10.74 TMO 10-K 2007 Exhibit 10.74 (Letter Agreement with Alan Malus)
- 10.75 TMO 10-K 2007 Exhibit 10.75 (Description of Amendments)
- 10.76 TMO 10-K 2007 Exhibit 10.76 (Amendment to Equity Incentive Plan)
- 10.77 TMO 10-K 2007 Exhibit 10.77 (Amendment to Employees Equity Incentive Plan)
- 10.78 TMO 10-K 2007 Exhibit 10.78 (Amendment to Directors Stock Option Plan)
- 10.79 TMO 10-K 2007 Exhibit 10.79 (Amendment to 2005 Stock Incentive Plan)
- 10.80 TMO 10-K 2007 Exhibit 10.80 (Amendment to 2005 Equity and Incentive Plan)
- 10.81 TMO 10-K 2007 Exhibit 10.81 (Amendment to 2001 Equity Incentive Plan)
- 21 TMO 10-K 2007 Exhibit 21 (Subsidiaries of the Registrant)
- 23.1 Tmmo 10-K 2007 Exhibit 23.1 (PWC Consent)
- 31.1 TMO 10-K 2007 Exhibit 31.1 (Certification)
- 31.2 TMO 10-K 2007 Exhibit 31.2 (Certification)
- 32.1 TMO 10-K 2007 Exhibit 32.1 (Certification)
- 32.2 TMO 10-K 2007 Exhibit 32.2 (Certification)
Related press release
TMO similar filings
Filing view
External links
Exhibit 23.1
CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM
We hereby consent to the incorporation by reference in the Registration Statements on Form S-8 (No. 33-37867, 33-51189, 33-54347, 33-54453, 33-61561, 333-90761, 333-90823, 333-48432, 333-43698, 333-40576, 333-33070, 333-33068, 333-33058, 333-33066, 333-33060, 333-33072, 333-62004, 333-76670, 333-83470, 333-127246, 333-138577, 333-146068 and 333-148334) of Thermo Fisher Scientific Inc. of our report dated February 27, 2008 relating to the consolidated financial statements, financial statement schedule and the effectiveness of internal control over financial reporting, which appears in this Form 10-K.
PricewaterhouseCoopers LLP
Boston, Massachusetts
February 27, 2008